Clinical Trial Details
— Status: Active, not recruiting
Administrative data
| NCT number |
NCT02004639 |
| Other study ID # |
FEMH No.101127-F |
| Secondary ID |
|
| Status |
Active, not recruiting |
| Phase |
N/A
|
| First received |
November 28, 2013 |
| Last updated |
December 4, 2013 |
| Start date |
March 2013 |
Study information
| Verified date |
December 2013 |
| Source |
Far Eastern Memorial Hospital |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
Taiwan: Institutional Review Board |
| Study type |
Interventional
|
Clinical Trial Summary
Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early detection, and
Physical Therapy Intervention
Description:
The optimal management of head and neck squamous cell carcinoma typically involves primary
surgical resection, and the indications for adjuvant radiotherapy are based on pathologic
markers of intermittent - and high-risk disease, which include positive margins,
extracapsular nodal extension, lymphovascular invasion, and perineural invasion (1-3).
Trismus is one of long term sequelae of radiotherapy for head and neck cancer patient. The
prevalence of trismus after head and neck oncology treatment could be as high as 42% (4). It
is significantly reducing nutrition due to impaired mastication (5). The loss of function
appears to be related to damage and fibrosis to the muscles of mastication. Radiation
therapy involving the temporomandibular joint, the pterygoid muscles, the temporalis or the
masseter muscle is most likely to result in trismus (5, 6). Moreover, there may be scar
tissue from radiation or surgery, nerve damage, or a combination of these factors (6, 7). In
addition, the doses of RT levels in excess of 60 Gy (8) or the configuration of the
radiation field increasing (9) are more likely to cause trismus. These data were documenting
the clinical results of conventional radiotherapy (RT).
Recently, extensive data suggest that intensity-modulated radiation therapy (IMRT) is safe
and efficacious in the adjuvant setting for oral cavity cancer (OCC) (10-12). Hsiung et al.
(13) and Chen et al. (14) confirmed that radiation induced trismus progressed over time and
improved by IMRT. Hsiung et al. (13) found the averages of normalized maximal interincisal
distance (MID) were 94% and 98.1% at 5 ms and 12 ms post-IMRT, respectively. In addition,
only 0.2 mm the deterioration of radiation-induced trismus in the period from 12-18 months
post-IMRT was noted. Moreover, Chen et al. (14) also confirmed that radiation induced
trismus progressed over time and improved by IMRT. However, Kent et al. (15) examined the
incidence of trismus in IMRT group compared to conventional radiotherapy group. There was no
significant difference in the maximum vertical dimension between the IMRT and the
conventional RT groups, (38.8 ± 9.0 vs 33.7 ± 10.1 mm, respectively, p = 0.11).
Helical tomotherapy (HT) is conceptually regarded an image-guided IMRT. HT was designed and
developed with advantages in sharper dose gradients and better normal tissue sparing. Our
and the other clinical experience of using HT for locally advanced head and neck cancer had
achieved encouraging results along with less toxicity, such lower percentage of dermatitis
and xerostomia when compared with previous reports (16-18). HT provides better normal tissue
sparing and sharper dose gradients than IMRT (19, 20).Chen et al. (19) compared HT and IMRT
for nasopharyngeal carcinoma and noted that HT significantly reduced dose to the
contralateral parotid gland and improved dose homogeneity to the PTVs. Additionally, HT
reduced mean doses to brainstem (p = 0.02), larynx (p = 0.03), and oral cavity (p = 0.03).
Similarly, for head-and-neck cancer, HT plans also provided favorably results compared with
the step-and-shoot IMRT plans. They are expected to be able to reduce the parotid normal
tissue (average 6.5 Gy) complication probability further, keeping similar target dose
homogeneity (21). Furthermore, HT provided better mandible sparing than IMRT with mean dose
decreased from 34.9 Gy (IMRT) to 30.7 Gy (HT) (20). However, can HT provide better normal
tissue sparing to reduce the incidence of trismus? It's still an interesting issue to
discuss.
In our 4-year initial clinical experience of 39 postoperative OCC patients treated with HT,
we noted the incidences of grade 1 and grade 2, 3 trismus [according to the Common
Terminology Criteria for Adverse Events v3.0 (CTCAE v3.0) ] appear inversely trend in time
sequence with post-HT treatment (Fig. 1). These observations hint the possible of decreasing
late complications of HT by better normal tissue sparing and sharper dose gradients (16-18)
and responses to radiation induced trismus improved by IMRT (13, 14).
According to previous study (6), Magnetic resonance imaging (MRI) could provide advantage
findings in masticator structures in patients with trismus developing after radiotherapy for
nasopharyngeal carcinoma (NPC). The abnormalities comprising radiotherapy-induced masticator
muscle fibrosis or inflammation, denervation atrophy of the masticator muscles secondary to
mandibular nerve damage, osteoradionecrosis change of mandibular rami, perimasticator
fibrosis extending into the masticator space and post RT damage of the parotid gland. The
presence of several MRI abnormalities in the masticator structures of patients with trismus
after radiotherapy suggests that trismus is multifactorial. However, there was no good
correlation data between the severities of trismus with these image findings and thus these
changes may possible due to non-specific inflammatory and fibrosis reactions after
radiation. Also, there was no correlation data between radiation dosages with these
abnormality, so all these findings may also result from other causes such as surgery or
chemotherapy. Therefore, we try to evaluate MRI examinations performed in patients before
and after trismus establishing following radiotherapy for OCC patients, in order to identify
the range and frequency of underlying diseases that may cause this complication. We
retrospect the OCC patients using MRI signal abnormality scores (SA score), separating the
patient according to their clinical trismus grading into three groups, the mean SA score of
grade 0 patient is 8.5, grade 1 is 6.76 and grade 2 is 4.87. Compared with group 2 patients,
there are statistically significant differences between group 1 (p= .04) as well as group 0
(p= .02), respectively. It means the SA score could correspond to the trismus grade (Fig.
2).
Rehabilitation training can improve swallow function and slow down the progress of trismus
in NPC patients following radiotherapy. The efficacy rate (percentage of patients with
excellent or effective results) of rehabilitation group was higher than that of control
group (77% vs. 43%), and the difference was statistically significant (p = 0.02). The
efficacy rate of trismus in the rehabilitation group was significantly higher than that of
the control group (64% vs. 28%, p = 0.02) (22). Using Therabite Jaw Motion Rehabilitation
System (Therabite Corporation, Bryn Mawr, PA) for maintaining and/or improving mandibular
range of motion in post-irradiated patients had been reported (23). They noted net increase
in maximal interincisal distance ( MID) of Therabite group (13.6 mm [+/- 1.6 mm]) was
significantly greater than unassisted exercise group (6.0 mm [+/- 1.8 mm]) and mechanically
assisted mandibular mobilization with stacked tongue depressors combined with unassisted
exercise group (4.4 mm [+/- 2.1 mm]) (P < .05) at week 6 and thereafter. These data
supported the benefits of rehabilitation for trismus following RT. However, rehabilitation
following new RT techniques have synchronic effect to improve patient's quality of life are
another interesting points need to discuss.
Acupuncture is an ancient Chinese method to treat diseases and relieve pain.
Electro-acupuncture (EA) is one of many physical measures used to relieve musculoskeletal
pain and to improve the associated restricted range of motion. Furthermore, electrical
stimulation via skin patch electrodes is as effective as EA. Low frequency (2 Hz) and high
frequency (100 Hz) of EA selectively induces the release of enkephalins and dynorphins in
both experimental animals and humans. Clinical studies suggest its effectiveness for the
treatment of various types of pain and spinally induced muscle spasm (24). In addition,
acupuncture-like stimulation exerts physiologic effects on the central nervous system,
mediated presumably by muscle afferent fibers. The effects may be relevant to relief of
muscle spasm and musculoskeletal pain, and restoration of mobility (25). Moreover, the
combined method of acupuncture with pressure on otopoints (the combination group) was used
to treat with facial spasm. The total effective rates of the combination group, the
acupuncture group and the pressure on otopoints group were 95.4%, 92.1% and 62.5%
respectively; and the cure rates were 38.4%, 15.8% and 5% respectively. The differences in
results of the three groups indicated that the therapeutic effectiveness of the combined
method of acupuncture with pressure on otopoints is better than the other two therapeutic
methods (26).These data hit the potential benefits of combination of EA and physical
therapy. Moreover, electrical stimulation via skin patch electrodes is as effective as EA
(24). Therefore, the effects of physical therapy combined with skin patch electrodes with
different frequency maybe better than physical therapy alone following CCRT or RT are
another interesting issue to discuss. Therefore, we designed the current prospective
measurement study with 3 years of follow-up to evaluate the incidence and severity of
radiation-induced trismus after IMRT and HT following physical therapy with or without
electrical stimulation via skin patch electrodes using MRI to assess relevant pretreatment
factors, treatment-related factors, and dosimetric parameters.
Specific Aims:
For Year 1:
1. To clarify the optimal doses of each muscle for those who with mild or non-trismus
treated by IMRT or HT with retrospective clinical data
2. To testify whether MRI findings can have good correlation with the radiation dose and
also clinical severity of trismus.
3. To testify whether IMRT or HT plan can achieve the optimal doses by re-plan same
patients with new constrains. .
For Year 2:
1. To clarify whether newly planning techniques of IMRT or HT can decrease the incidence
and progression of trismus for head and neck patients.
2. To testify whether MRI findings can serve as predictors for trismus during follow.
3. To clarify whether adding rehabilitation can provide synchronous benefits for trismus
following newly RT planning techniques.
For Year 3:
1. To clarify whether HT can provide better clinical results for decreasing trismus for
head and neck patients than IMRT.
2. To clarify whether MR image abnormalities of head and neck patient after IMRT will
change after early introduction of rehabilitation.
3. To clarify whether electrical stimulation via skin on specific points combined with
rehabilitation can provide synchronous benefits than rehabilitation alone for trismus
following newly RT planning techniques.
